Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11001619 GIP agonist compounds and methods

Patent 11001619 was granted and assigned to Zealand Pharma A/S on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Zealand Pharma A/S

Current Assignee

Zealand Pharma A/S

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11001619

Patent Inventor Names

Pia Nørregaard0

Bjarne Due Larsen0

Jacob Ulrik Fog0

Maria Alexandrovna Deryabina0

Anne Pernille Tofteng Shelton0

Date of Patent

May 11, 2021

Patent Application Number

16281347

Date Filed

February 21, 2019

Patent Citations

‌

US Patent 10100097 GIP-GLP-1 dual agonist compounds and methods

‌

US Patent 10004786 Acylated glucagon analogues

‌

US Patent 10093713 GIP-GLP-1 dual agonist compounds and methods

‌

US Patent 10131702 Glucagon-GLP-1-GIP triple agonist compounds

Patent Primary Examiner

‌

Thomas S Heard

Patent abstract

The present invention relates to acylated GIP analogues which have GIP agonist activity, and their use in the treatment of metabolic disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11001619 GIP agonist compounds and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API